An interventional study of Pain science education and virtual reality in Low Back Pain, sponsored by Aveiro University. Recruiting at 1 site in Portugal. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-03.
Sponsored by Aveiro University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Low Back Pain with a site in Portugal — 4 open to participants now, 4 under way, none of them phase 3. Low Back Pain · Portugal.
Among the 15 studies in Low Back Pain with a site in Portugal, this one is the 14th largest by planned enrollment, is one of 2 that started in 2026, is one of 13 with no phase, and was the 13th registered.
2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.
Browse Low Back Pain studies →4 of the 15 studies in Low Back Pain with a site in Portugal are open now. Recruiting first, the newest first:
Instituto Politécnico de Setúbal · Sites in Portugal
Ages 18–65 · Healthy volunteers
Escola Superior de Tecnologia da Saúde do Porto · Sites in Portugal
Ages 18+
Escola Superior de Tecnologia da Saúde do Porto · Sites in Portugal
Ages 18–30 · Healthy volunteers
A study can be open while its sites in Portugal have not opened yet or have stopped. Only those recruiting at a site in Portugal →
Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
First in 2013; this study’s year is marked. 2 started in 2026.
This study's planned enrollment of 12 is below the median of 60 across 2,369 interventional studies indexed under Low Back Pain.
Median enrollment 40 across the 15 interventional studies. Of the 8 that completed or were terminated, 1 (13%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 15 have an industry lead sponsor. The 10 most frequent:
Aveiro University is the lead sponsor of 59 studies on the registry; 14 are open to participants now.
Aveiro University has 4 studies filed under Low Back Pain — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 15 studies in Low Back Pain with a site in Portugal, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This is a single-case experimental design study enrolling individuals with chronic low back pain who will be receiving pain science education and virtual reality over 3 weeks.
The main objective of this study is to evaluate the potential of virtual reality in reducing pain intensity in individuals with primary chronic low back pain. Secondary objectives include analysing the impact of virtual reality on pain catastrophizing and fear of movement, as well as exploring participants' perspectives on the integration of virtual reality into the intervention plan.
The study will be divided into three phases: baseline assessment, intervention, and post-intervention assessment. The baseline assessment phase will have a different duration for each participant.
At baseline, participants will complete several paper-based questionnaires (sociodemographic and anthropometric data; pain location, intensity and characteristics; pain catastrophizing; fear of movement; pain during movement; and pain-related disability). After completing all questionnaires, participants will receive a paper diary to complete daily at home. This diary will record information such as pain intensity, fear of movement, and pain catastrophizing.
Participants will return to the office only on the first day of the intervention phase, which will coincide with the first session. Sessions will be individual, will last between 30 and 45 minutes, and will take place with an interval of one to two days. The intervention phase will end on the 29th day of the study for all participants and consists of pain science education and virtual reality.
On the final day of the study (i.e., the 35th day), participants will complete the same questionnaires administered at baseline, with the addition of the Global Perceived Effect scale. At that time, the diary provided at the beginning of the study will be collected.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
There is only one arm. Participants will receive pain science education and virtual reality. This is a single case experimental design study.
Other: Pain science education and virtual reality
The intervention period will take place between the 5th and the 29th day of the study (i.e., 3 weeks), noting that each participant will have a specific day to start the intervention. Three sessions will be conducted per week, with a total of 6 to 10 sessions per participant. The first 6 sessions will last 45 minutes, and the remaining 4 sessions will last 30 minutes. The sessions will combine Pain Neuroscience Education (PNE) and Virtual Reality (VR) using the Meta Quest 3S.
Pain intensity
Measured using the numeric pain rating scale (end points: 0-10); 0 - minimum score, 10 - maximum score; higher scores mean higher pain intensity.
Time frame: Baseline (Day 1)
Pain intensity
Measured using the numeric pain rating scale (end points: 0-10); 0 - minimum score, 10 - maximum score; higher scores mean higher pain intensity.
Time frame: Daily (from day 1 to day 35)
Pain intensity
Measured using the numeric pain rating scale (end points: 0-10); 0 - minimum score, 10 - maximum score; higher scores mean higher pain intensity.
Time frame: End of the intervention (day 35)
pain mechanism
Assessed using the PainDetect questionnaire; range score: -1 (minimum) to 38 (maximum); scores are interpreted as a neuropathic component is unlikely (\<12), result is ambiguous (13-18) and neuropathic component is likely (\>19).
Time frame: Baseline (day 1)
pain mechanism
Assessed using the PainDetect questionnaire; -1 (minimum) to 38 (maximum); scores are interpreted as a neuropathic component is unlikely (\<12), result is ambiguous (13-18) and neuropathic component is likely (\>19).
Time frame: End of the intervention (day 35)
Pain intensity during movement
Measured using the numeric pain rating scale (end points: 0-10); 0 - minimum score, 10 - maximum score; higher scores mean higher pain intensity.
Time frame: Baseline (day 1)
Pain intensity during movement
Measured using the numeric pain rating scale (end points: 0-10); 0 - minimum score, 10 - maximum score; higher scores mean higher pain intensity.
Time frame: End of the intervention (day 35)
Perceived disability
Assessed using the Oswestry Disability Index; scores: 0 (minimum to 100 (maximum); higher scores mean higher disability
Time frame: Baseline (day 1)
Perceived disability
Assessed using the Oswestry Disability Index; scores: 0 (minimum to 100 (maximum); higher scores mean higher disability
Time frame: End of the intervention (day 35)
Catastrophizing
Assessed using the Pain Catastrophizing Scale; score range: 0 (minimum to 52 (maximum); higher scores mean higher catastrophizing.
Time frame: Baseline (day 1)
Catastrophizing
Assessed using the Pain Catastrophizing Scale; score range: 0 (minimum to 52 (maximum); higher scores mean higher catastrophizing.
Time frame: End of the intervention (day 35)
Fear of movement
Assessed using the Tampa Scale of kinesiophobia; score range: 13 (minimum to 52 (maximum); higher scores mean higher fear of movement.
Time frame: Baseline (day 1)
Fear of movement
Assessed using the Tampa Scale of kinesiophobia; score range: 13 (minimum to 52 (maximum); higher scores mean higher fear of movement.
Time frame: End of the intervention (day 35)
Knowledge on pain neurophysiology
Assessed using the Neurophysiology of Pain questionnaire; score range: 0 (minimum and 19 (maximum) and higher scores mean better pain knowledge.
Time frame: Baseline (day 1)
Knowledge on pain neurophysiology
Assessed using the Neurophysiology of Pain questionnaire; score range: 0 (minimum and 19 (maximum) and higher scores mean better pain knowledge.
Time frame: End of the intervention (day 35)
Global perception of change
Assessed using the Global Rating of Change Scale, which has 7 itens (1 = no changes; 2 = almost the same; 3 = slightly better; 4 = with some improvements; 5 = moderately better; 6 = better; and 7 = much better)and higher scores mean higher perceived improvement
Time frame: End of the intervention (day 35)
Catastrophizing
3 items of the Pain Catastrophizing Scale will be used daily (items 1, 2 and 13) each rated using a 5-item Likert scale; total score ranging from 0 (minimum) to 12 (maximum) with higher scores meaning higher catastrophizing.
Time frame: Daily (from day 1 to day 35)
Fear of movemently
3 items of the TAMPA Scale will be used daily (items 1, 3 and 12), each rated using a 4-item Likert scale; total score ranging from 3 (minimum) to 12 (maximum), with higher scores meaning higher fear of movement.
Time frame: Daily (from day 1 to day 35)
Started May 2026 (actual). Primary completion is estimated for Oct 2026, 5 months after the start.
Of 1,234 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's planned 5 months is below that.
Counting every sponsor, half of 1,290 studies reached it within 11 months; a quarter within 5 and three quarters within 27.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Aveiro University